Studies have shown that LINC00839 targets the mir-338-3p/GLUT1 axis to promote the cell proliferation, migration, invasion and glycolysis of neuroblastoma cells, resulting in the poor survival rate of patients with neuroblastoma (Sahu et al., 2018; Yang et al., 2021). The gene discussed is SLC2A1; the disease is neuroblastoma.